Bilirubin
Reviewed by Maurice Lichtenberg
Bilirubin is the predominant end-product of haem catabolism, formed when reticuloendothelial cells degrade senescent red blood cells; it circulates as unconjugated (indirect) bilirubin bound to albumin before hepatic uptake, conjugation with glucuronic acid, and biliary excretion. Elevated total bilirubin is classified as pre-hepatic (haemolysis), hepatic (hepatocellular dysfunction), or post-hepatic (biliary obstruction) based on the unconjugated-to-conjugated ratio and accompanying enzymes. Mildly elevated unconjugated bilirubin in isolation — as in Gilbert syndrome — is generally benign and is associated with a more favourable cardiovascular risk profile in observational data, possibly via bilirubin's antioxidant properties as a lipid-soluble radical scavenger. Severely elevated bilirubin is a marker of advanced liver failure and a component of prognostic scores such as MELD.
Sources
- Ziberna L, Martelanc M, Franko M, Passamonti S. (2016). Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells. *Scientific Reports*doi:10.1038/srep29240
- Bulmer AC, Bakrania B, Du Toit EF, Boon AC, Headrick JP. (2018). Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. *American Journal of Physiology – Heart and Circulatory Physiology*doi:10.1152/ajpheart.00417.2017
